Overview

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Status:
Completed
Trial end date:
2011-10-10
Target enrollment:
Participant gender:
Summary
The purpose of the study was to evaluate efficacy of prophylactic Ingavirin intake by people having contact with sick people infected with influenza and other acute respiratory viral infections
Phase:
Phase 3
Details
Lead Sponsor:
Valenta Pharm JSC
Treatments:
Pentanedioic acid imidazolyl ethanamide